Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children
Clinical trial NCT01333813 · COMPLETED
Trial details
- NCT number
- NCT01333813
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-26
- Primary completion
- 2011-09-28
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.